131 related articles for article (PubMed ID: 23608764)
1. Discovery of natural estrogen receptor modulators with structure-based virtual screening.
Cao X; Jiang J; Zhang S; Zhu L; Zou J; Diao Y; Xiao W; Shan L; Sun H; Zhang W; Huang J; Li H
Bioorg Med Chem Lett; 2013 Jun; 23(11):3329-33. PubMed ID: 23608764
[TBL] [Abstract][Full Text] [Related]
2. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening.
Shen J; Tan C; Zhang Y; Li X; Li W; Huang J; Shen X; Tang Y
J Med Chem; 2010 Jul; 53(14):5361-5. PubMed ID: 20553023
[TBL] [Abstract][Full Text] [Related]
3. Enhanced estrogen receptor beta (ERβ) selectivity of fluorinated carborane-containing ER modulators.
Ohta K; Ogawa T; Kaise A; Endo Y
Bioorg Med Chem Lett; 2013 Dec; 23(24):6555-8. PubMed ID: 24268550
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of bisphenol A analogs at estrogen receptors (ERs): discovery of an ERα-selective antagonist.
Maruyama K; Nakamura M; Tomoshige S; Sugita K; Makishima M; Hashimoto Y; Ishikawa M
Bioorg Med Chem Lett; 2013 Jul; 23(14):4031-6. PubMed ID: 23768907
[TBL] [Abstract][Full Text] [Related]
6. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.
Zhang L; Sedykh A; Tripathi A; Zhu H; Afantitis A; Mouchlis VD; Melagraki G; Rusyn I; Tropsha A
Toxicol Appl Pharmacol; 2013 Oct; 272(1):67-76. PubMed ID: 23707773
[TBL] [Abstract][Full Text] [Related]
7. Design of a highly selective and potent class of non-planar estrogen receptor β agonists.
Sundén H; Ma JN; Hansen LK; Gustavsson AL; Burstein ES; Olsson R
ChemMedChem; 2013 Aug; 8(8):1283-94. PubMed ID: 23784708
[TBL] [Abstract][Full Text] [Related]
8. New scaffolds for the design of selective estrogen receptor modulators.
Martín-Santamaría S; Rodríguez JJ; de Pascual-Teresa S; Gordon S; Bengtsson M; Garrido-Laguna I; Rubio-Viqueira B; López-Casas PP; Hidalgo M; de Pascual-Teresa B; Ramos A
Org Biomol Chem; 2008 Oct; 6(19):3486-96. PubMed ID: 19082149
[TBL] [Abstract][Full Text] [Related]
9. ER subtype selectivity of m-carborane-containing phenols: C-alkyl groups on the m-carborane cage enhance ERα selectivity.
Ohta K; Ogawa T; Kato K; Oda A; Endo Y
Bioorg Med Chem Lett; 2019 Aug; 29(16):2290-2293. PubMed ID: 31248773
[TBL] [Abstract][Full Text] [Related]
10. Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist/antagonist activity profiles for estrogen receptors alpha and beta.
Roelens F; Heldring N; Dhooge W; Bengtsson M; Comhaire F; Gustafsson JA; Treuter E; De Keukeleire D
J Med Chem; 2006 Dec; 49(25):7357-65. PubMed ID: 17149865
[TBL] [Abstract][Full Text] [Related]
11. Characterization of steroid hormone receptor activities in 100 hydroxylated polychlorinated biphenyls, including congeners identified in humans.
Takeuchi S; Shiraishi F; Kitamura S; Kuroki H; Jin K; Kojima H
Toxicology; 2011 Nov; 289(2-3):112-21. PubMed ID: 21843587
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α.
Eignerová B; Sedlák D; Dracínský M; Bartunek P; Kotora M
J Med Chem; 2010 Oct; 53(19):6947-53. PubMed ID: 20812681
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
Güngör T; Chen Y; Golla R; Ma Z; Corte JR; Northrop JP; Bin B; Dickson JK; Stouch T; Zhou R; Johnson SE; Seethala R; Feyen JH
J Med Chem; 2006 Apr; 49(8):2440-55. PubMed ID: 16610787
[TBL] [Abstract][Full Text] [Related]
14. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells.
Mueller SO; Simon S; Chae K; Metzler M; Korach KS
Toxicol Sci; 2004 Jul; 80(1):14-25. PubMed ID: 15084758
[TBL] [Abstract][Full Text] [Related]
15. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
[TBL] [Abstract][Full Text] [Related]
16. Cycloartane triterpenoids from the stems of Schisandra glaucescens and their bioactivity.
Zou J; Jiang J; Diao YY; Yang LB; Huang J; Li HL; Du X; Xiao WL; Pu JX; Sun HD
Fitoterapia; 2012 Jul; 83(5):926-31. PubMed ID: 22537642
[TBL] [Abstract][Full Text] [Related]
17. Target specific virtual screening: optimization of an estrogen receptor screening platform.
Knox AJ; Meegan MJ; Sobolev V; Frost D; Zisterer DM; Williams DC; Lloyd DG
J Med Chem; 2007 Nov; 50(22):5301-10. PubMed ID: 17918820
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.
Paterni I; Granchi C; Katzenellenbogen JA; Minutolo F
Steroids; 2014 Nov; 90():13-29. PubMed ID: 24971815
[TBL] [Abstract][Full Text] [Related]
19. Selenophenes: Introducing a New Element into the Core of Non-Steroidal Estrogen Receptor Ligands.
Zhang S; Wang Z; Hu Z; Li C; Tang C; Carlson KE; Luo J; Dong C; Katzenellenbogen JA; Huang J; Zhou HB
ChemMedChem; 2017 Feb; 12(3):235-249. PubMed ID: 27976818
[TBL] [Abstract][Full Text] [Related]
20. 6H-Benzo[c]chromen-6-one derivatives as selective ERbeta agonists.
Sun W; Cama LD; Birzin ET; Warrier S; Locco L; Mosley R; Hammond ML; Rohrer SP
Bioorg Med Chem Lett; 2006 Mar; 16(6):1468-72. PubMed ID: 16412638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
